Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maximum Tolerated Dose”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00095537
What this trial is testing

BMS-599626 in Patients With Advanced Solid Malignancies

Who this might be right for
CancerMetastases
Bristol-Myers Squibb 60
Early research (Phase 1)Study completedNCT01976741
What this trial is testing

Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor (Rogaratinib)

Who this might be right for
Neoplasms
Bayer 168
Early research (Phase 1)Ended earlyNCT04809805
What this trial is testing

Learn How Safe BAY2666605 is, How it Affects the Body, How it Moves Into, Through and Out of the Body, the Maximum Amount That Can be Given and Its Action Against Tumors in Adult Participants With Skin Cancer That Has Spread to Other Parts of the Body and Other Types of Advanced Cancer

Who this might be right for
Metastatic Melanoma and Other Solid Tumors
Bayer 5
Early research (Phase 1)UnknownNCT03468751
What this trial is testing

Phase 1 Study of HLX10, a Monoclonal Antibody Targeting Programmed Death-1 (PD-1) in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Henlix, Inc 30
Early research (Phase 1)Ended earlyNCT02168725
What this trial is testing

Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid Tumors

Who this might be right for
NeoplasmsAdvanced Solid Tumor
Traws Pharma, Inc. 26
Early research (Phase 1)Study completedNCT00493155
What this trial is testing

A Multiple Ascending Dose Study of R1530 in Patients With Advanced Solid Tumors.

Who this might be right for
Neoplasms
Hoffmann-La Roche 48
Testing effectiveness (Phase 2)Ended earlyNCT00179725
What this trial is testing

Phase I/II Open-Label, Dose Escalation Study To Determine The Maximum Tolerated Dose And To Evaluate The Safety Profile of Lenalidomide (Revlimid® CC-5013) With Liposomal Doxorubicin In Subjects With Advanced Ovarian and Primary Peritoneal Carcinoma

Who this might be right for
Ovarian Cancer
Celgene Corporation 60
Early research (Phase 1)Study completedNCT00941863
What this trial is testing

Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)

Who this might be right for
Carcinoma
Bayer 158
Testing effectiveness (Phase 2)Ended earlyNCT01573338
What this trial is testing

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 When Given Together With Chemotherapy and the Effectiveness of This Combination Treatment in Shrinking a Specific Type of Lung Tumors (Small Cell Lung Cancer)

Who this might be right for
Small Cell Lung Carcinoma
Bayer 43
Early research (Phase 1)WithdrawnNCT00478517
What this trial is testing

TETRAM 2. Treatment With Erythropoetin in Patients With Spinal Trauma With Neurological Deficit, Maximum Tolerated Dose Study

Who this might be right for
Spinal Trauma With Neurological Deficit
Hospices Civils de Lyon 20
Early research (Phase 1)UnknownNCT00881816
What this trial is testing

Dose Escalation Study of Liposomal Paclitaxel Plus Capecitabine in Chinese Patients With Advanced Gastric Carcinoma

Who this might be right for
Advanced Gastric Carcinoma
Nanjing Sike Pharmaceutical Co., Ltd. 15
Early research (Phase 1)Looking for participantsNCT05365659
What this trial is testing

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

Who this might be right for
B-cell Non-Hodgkin LymphomaDiffuse Large B Cell LymphomaFollicular Lymphoma+2 more
Iksuda Therapeutics Ltd. 140
Early research (Phase 1)Study completedNCT00446290
What this trial is testing

Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer

Who this might be right for
Stomach Cancer
Asan Medical Center 22
Early research (Phase 1)Ended earlyNCT01065623
What this trial is testing

Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Bayer 2
Testing effectiveness (Phase 2)Study completedNCT00003732
What this trial is testing

Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Cancer

Who this might be right for
Ovarian Cancer
Rigshospitalet, Denmark 80
Early research (Phase 1)Study completedNCT03292783
What this trial is testing

This is a Study to Evaluate the Safety and Tolerability of the Study Drug ABL001, and to Determine the Maximum Tolerated Dose and/or Recommended Phase 2 Study Dose of ABL001

Who this might be right for
Advanced Solid Tumors
ABL Bio, Inc. 45
Early research (Phase 1)Study completedNCT07017114
What this trial is testing

Pentoxifylline PKB171 Gel in Healthy Females Volunteers

Who this might be right for
SafetyPharmacokineticsMaximum Tolerated Dose
Prokrea BCN, S.L. 30
Early research (Phase 1)Ended earlyNCT01064089
What this trial is testing

Dose Escalation of HSP990 in Japan/Korea

Who this might be right for
Advanced Solid Tumors
Novartis Pharmaceuticals 17
Early research (Phase 1)Study completedNCT01682616
What this trial is testing

A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

Who this might be right for
Small Lymphocytic LymphomaChronic Lymphocytic Leukemia
AbbVie 49
Early research (Phase 1)Enrolling By InvitationNCT06169579
What this trial is testing

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers

Who this might be right for
Advanced Solid Tumor
Shenzhen NewDEL Biotech, Co., Ltd 96
Next Page